Department of Medicine
Total Page:16
File Type:pdf, Size:1020Kb
Department of Medicine Endocrinology and MedStar Diabetes Institute PEER REVIEWED PUBLISHED PAPERS Aktolun C, Amendoeira I, Barczynski M, Bible KC, Duntas LH, Elisei R, Fuhrer-Sakel D, Handkiewicz-Junak D, Hoffmann M, Jarzab B, Leenhardt L, Luster M, Musholt TJ, Newbold K, Nixon IJ, Smit J, Sobrinho-Simoes M, Sosa JA, Tuttle RM MD, Verburg F, Wartofsky L. (2019). European perspective on the 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Proceedings of an interactive international symposium. Thyroid, 29, 7-26. Baloch ZW, Burman KD, Carty SE, Chiosea SI, Ferris RL, Figge JJ, Folek JM, Gomes-Lima C, Gooding WE, Haugen BR, Khawaja RA, Kundra P, Lloyd RV, Loh KS, Mandel S, Marshall CB, Mayson S, McCoy KL, Nga ME, Ngiam KY, Nikiforov YE, et al…(2019). Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: A prospective blinded multicenter study. Neonatology, 115, 108-115. Bardsley JK, Baker KM, Smith KM, Magee MF. (2019). Diabetes education for behavioral health inpatients: Challenges and opportunities. Journal of the American Psychiatric Nurses Association, :1078390319878781, Oct 05. (preprint) Bikas A, Jensen K, Patel A, Costello J, Kaltsas G, Hoperia V, Wartofsky L, Burman K, Vasko V. (2019). Mitotane induces mitochondrial membrane depolarization and apoptosis in thyroid cancer cells. International Journal of Oncology, 55, 7-20. Boyle J, Patronas NJ, Smirniotopoulos J, Herscovitch P, Dieckman W, Millo C, Maric D, Chatain GP, Hayes CP, Benzo S, Scott G, Edwards N, Ray Chaudhury A, Lodish MB, Sharma S, Nieman LK, Stratakis CA, Lonser RR, Chittiboina P. (2019). CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing's disease. Endocrine, 65, 155-165. Chen SH, Ip EH, Magee MF, Youssef GA. (2019). Gleaning information for cognitive operations from Don't Know responses in cognitive and noncognitive assessments. Multivariate Behavioral Research, 54, 159-172. Fazeli S, Paal E, Maxwell JH, Burman KD, Nylen ES, Khosla SG. (2019). Salutary response to targeted therapy in anaplastic thyroid cancer. Journal of Investigative Medicine High Impact Case Reports, 7:2324709619890942. Gomes-Lima C, Wartofsky L, Burman K. (2019). Can reverse T3 assay be employed to guide T4 vs. T4/T3 therapy in hypothyroidism? Frontiers in Endocrinology, 10, 856. Gomes-Lima CJ, Wu D, Rao SN, Punukollu S, Hritani R, Zeymo A, Deeb H, Mete M, Aulisi EF, Van Nostrand D, Jonklaas J, Wartofsky L, Burman KD. (2019). Brain metastases from differentiated thyroid carcinoma: Prevalence, current therapies, and outcomes. Journal of the Endocrine Society, 3, 359-371. Klubo-Gwiezdzinska J, Auh S, Gershengorn M, Daley B, Bikas A, Burman K, Wartofsky L, Urken M, Dewey E, Smallridge R, Chindris AM, Kebebew E. (2019). Association of thyrotropin suppression with survival outcomes in patients with intermediate- and high-risk differentiated thyroid cancer. JAMA Network Open, 2, e187754. 1 Low Wang CC, Everett BM, Burman KD, Wilson PWF. (2019). Cardiovascular safety trials for all new diabetes mellitus drugs? Circulation, 139, 1741-1743. Magee MF, Baker KM, Fernandez SJ, Huang CC, Mete M, Montero AR, Nassar CM, Sack PA, Smith K, Youssef GA, Evans SR. (2019). Redesigning ambulatory care management for uncontrolled type 2 diabetes: A prospective cohort study of the impact of a Boot Camp model on outcomes. BMJ Open Diabetes Research & Care, 7, e000731. Montero AR, Dubin JS, Sack P, Magee MF. (2019). Future technology-enabled care for diabetes and hyperglycemia in the hospital setting. World Journal of Diabetes, 10, 473-480. Nassar CM, Montero A, Magee MF. (2019). Inpatient diabetes education in the real world: An overview of guidelines and delivery models. Current Diabetes Reports, 19, 103. Papoian V, Ylli D, Felger EA, Wartofsky L, Rosen JE. (2019). Evaluation of thyroid hormone replacement dosing in overweight and obese patients after a thyroidectomy. Thyroid, Oct 01. (preprint) Shobab L, Gomes-Lima CJ, Zeymo A, Feldman R, Jonklaas J, Wartofsky L, Burman KD. (2019). Clinical, pathological and molecular profiling of radioactive iodine refractory differentiated thyroid cancer. Thyroid, Jul 18. (preprint) Smith KM, Baker KM, Bardsley JK, McCartney P, Magee M. (2019). Redesigning hospital diabetes education: A qualitative evaluation with nursing teams. Journal of Nursing Care Quality, 34, 151-157. Wu D, Gomes Lima CJ, Moreau SL, Kulkarni K, Zeymo A, Burman KD, Wartofsky L, Van Nostrand D. (2019). Improved survival after multimodal approach with 131I treatment in patients with bone metastases secondary to differentiated thyroid cancer. Thyroid, 29, 971-978. Wu D, Gomes-Lima CJ, Bloom G, Burman KD, Wartofsky L, Van Nostrand D. (2019). Nationwide survey of implementation of 2011 Nuclear Regulatory Commission policy on release of patients after 131I therapy. Journal of Nuclear Medicine, Aug 26. (preprint) Wu D, Ylli D, Heimlich SL, Burman KD, Wartofsky L, Van Nostrand D. (2019). I-124 PET/CT versus conventional radioiodine imaging in differentiated thyroid cancer: A review. Thyroid, Aug 27. (preprint) Ylli D, Klubo-Gwiezdzinska J, Wartofsky L. (2019). Thyroid emergencies. Polish Archives of Internal Medicine, 129, 526-534. Ylli D, Patel A, Jensen K, Li ZZ, Mendonca-Torres MC, Costello J, Gomes-Lima CJ, Wartofsky L, Burman KD, Vasko VV. (2019). Microfluidic droplet digital PCR Is a powerful tool for detection of BRAF and TERT mutations in papillary thyroid carcinomas. Cancers, 11, 12. Ylli D, Van Nostrand D, Wartofsky L. (2019). Conventional radioiodine therapy for differentiated thyroid cancer. Endocrinology & Metabolism Clinics of North America, 48, 181-197. Youssef G, Ip EH, Magee M, Chen SH, Wallia A, Pollack T, Touma E, Bourges C, Brecker L. (2019). Validity and reliability of a (brief) diabetes "survival skills" knowledge test: KNOW Diabetes. Diabetes Educator, 145721719828064, Feb 25. (preprint) 2 ABSTRACTS, POSTERS, AND PRESENTATIONS Baral N, Basyal B, Sharma M. (2019). Prolonged hypoglycemia after insulin glargine overdose. Poster presented at MedStar Health-Georgetown University Research Symposium, North Bethesda, MD. Baral N, Wartofsky L, Sharma M. (2019). Thyrotoxic Hashimoto's Disease: Is it Graves? Hyrotoxicosis or “Hashitoxicosis”? Poster presented at MedStar Health-Georgetown University Research Symposium, North Bethesda, MD. Baral N, Wartofsky L, Sharma MB. (2019). Thyrotoxic Hashimoto's Disease: Is it Graves' thyrotoxicosis or "Hashitoxicosis"? Abstract presented at ENDO 2019, Endocrine Society, New Orleans, LA. Bikas A, Jensen K, Patel A, Larin O, Wartofsky L, Burman K, Vasko V. (2019). Identification of molecular targets in distant metastases of patients with thyroid cancer. Poster presented at MedStar Health-Georgetown University Research Symposium, North Bethesda, MD. Distajo R, Al-Jundi M, Nassar C, Magee M. (2019). Maintaining momentum after the Diabetes Boot Camp: Empathy training for internal medicine residents to support maintenance of improvements in glycemic control among adults with type 2 diabetes who have completed an intensive cloud-based tele-monitoring, survival skills self- management, and medications management intervention. Poster presented at MedStar Health-Georgetown University Research Symposium, North Bethesda, MD. Gomes Lima C, Kwagyan J, King F, Fernandez S, Burman K, Veytsman I. (2019). A comprehensive meta-analysis of endocrine immune-related adverse events of immune checkpoint inhibitors and outcomes in head and neck cancer and lung cancer. Poster presented at MedStar Health-Georgetown University Research Symposium, North Bethesda, MD. Gomes-Lima C, Shobab L, Wu D, Yll D, Bikas A, Avadhanula S, Parikh T, Chittimoju S, McCoy M, Rao S, Feldman R, Lee W, Wexler J, Jonklaas J, Wartofsky L, Burman K. (2019). Do molecular profiles of primary versus metastatic radioiodine refractory differentiated thyroid cancer differ? Poster presented at MedStar Health-Georgetown University Research Symposium, North Bethesda, MD. Lai V, Burman KD. (2019). Primary hyperparathyroidism and bone density in patients with a history of Roux-en-Y gastric bypass. Abstract presented at 14th Annual Academic Surgical Congress (ACS), Houston, TX. Nassar C, Fernandez A, Mete M, Montero A, Sack P, Youssef G, Magee M. (2019). Boot camp leverages real world EMR data to generate evidence of impact on type 2 diabetes care management. Poster presented at MedStar Health-Georgetown University Research Symposium, North Bethesda, MD. Parikh T, Sharma M, Hegde A. (2019). Refractory thyroid storm: Role of single pass albumin dialysis (SPAD). Abstract presented at ENDO 2019, Endocrine Society, New Orleans, LA. Parikh T, Sharma MB. (2019). Dual endocrinopathies following single dose of pembrolizumab therapy. Abstract presented at ENDO 2019, Endocrine Society, New Orleans, LA. Shobab L, Wartofsky L, Jonklaas J, Vasko V, Jensen K, Zeymo A, Burman K. (2019). Sex-bias in clinicopathological presentation of patients with differentiated thyroid cancer. Abstract presented at ENDO 2019, Endocrine Society, New Orleans, LA. 3 Sirna S, Shekhar S, Sharma M. (2019). Adrenal incidentaloma in critical illness: A diagnostic dilemma. Poster presented at MedStar Health-Georgetown University Research Symposium, North Bethesda, MD. Sirna SJ, Shekhar S, Sharma MB. (2019). Adrenal incidentaloma evaluation in critical illness: A diagnostic dilemma. Abstract presented at ENDO 2019, Endocrine Society, New Orleans, LA. Veluru M, Vallurupalli SR, Vangimalla SS, Sharma M. (2019).